A carregar...
Recent advances in antiemetics: new formulations of 5HT(3)-receptor antagonists
PURPOSE: To discuss new therapeutic strategies for chemotherapy-induced nausea and vomiting (CINV) involving 5-hydroxytryptamine type 3 (5HT(3))-receptor antagonists (RAs). SUMMARY: CINV remains poorly controlled in patients receiving moderately emetogenic chemotherapy (MEC) or highly emetogenic che...
Na minha lista:
| Publicado no: | Cancer Manag Res |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6037149/ https://ncbi.nlm.nih.gov/pubmed/30013391 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S166912 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|